On Friday, the U.S. Food and Drug Administration (FDA) approved Tonix Pharmaceuticals Holding Corp.’s (NASDAQ:TNXP) Tonmya (cyclobenzaprine HCl sublingual tablets) for fibromyalgia in adults. Fibromyalgia is a chronic condition characterized by widespread musculoskeletal pain, fatigue, and other symptoms like sleep disturbances and cognitive difficulties. Tonmya is a non-opioid, once-daily bedtime analgesic with a unique sublingual (under the tongue) formulation that is …
Read More »Tag Archives: Drug
US FDA approves Tonix Pharma's drug to manage pain related to chronic condition – Reuters
US FDA approves Tonix Pharma’s drug to manage pain related to chronic condition Reuters Tonix Pharmaceuticals Holding Second Quarter 2025 Earnings: Misses Expectations Yahoo Finance With FDA nod, Tonix’s Tonmya becomes first new fibromyalgia treatment in more than 16 years Fierce Pharma Anticipating TNX-102 SL’s Addition to the Fibromyalgia Toolkit, with Andrew Sharobeem, DO HCPLive Tonix Pharmaceuticals stock halted ahead of FDA approval news Investing.com …
Read More »New drug could eliminate metastatic cancer tumors
Share on PinterestAn injectable experimental drug made aggressive breast and skin cancer tumors disappear in a small trial. Image credit: Alina Kostrytsia/Getty Images Scientists have developed a new cancer drug that can be injected directly into tumors. The treatment, an enhanced CD40 agonist, was successful in its first trial of 12 human participants. Six people in the group saw their …
Read More »Novo Nordisk’s obesity drug Wegovy cleared to treat live disease MASH
Novo Nordisk’s obesity drug Wegovy was cleared by U.S. regulators on Friday to treat an increasingly common liver disease, adding to the list of conditions for which the blockbuster therapy is now approved. The Food and Drug Administration granted accelerated approval to Wegovy for patients with metabolic dysfunction-associated steatohepatitis, or MASH, with moderate to advanced liver scarring. The decision was …
Read More »ADHD drug treatment and risk of negative events and outcomes – Hacker News
ADHD drug treatment and risk of negative events and outcomes Hacker News ADHD drugs have wider life benefits, study suggests BBC ADHD medication linked to lower risk of suicidal behaviours, study suggests The Guardian Early ADHD Treatment Tied to Less Risk of Crime, Car Accidents MedPage Today ADHD medication reduces risk of suicide and criminal behaviour, study finds The Independent Source link
Read More »FDA Approves Tonix’s Tonmya for Fibromyalgia, First New Drug in 15 Years
Tonix Pharmaceuticals (Nasdaq: TNXP) has received FDA approval for Tonmya™, a groundbreaking treatment for fibromyalgia in adults – the first new therapy approved in over 15 years. This non-opioid, sublingual tablet is designed for once-daily bedtime use with rapid bloodstream absorption. Two pivotal Phase 3 clinical trials involving nearly 1,000 patients demonstrated …
Read More »Eli Lilly hikes Mounjaro prices in the UK to make weight-loss drug cheaper in the US
Facebook Tweet Email Link London — Eli Lilly will significantly increase the price of its weight-loss drug Mounjaro in the United Kingdom in a bid to bring down prices in the United States after weeks of pressure from the Trump administration. The US drugmaker announced Thursday that it was rolling out price hikes across Europe, with prices rising in the …
Read More »The Rockefeller University » Immunotherapy drug eliminates aggressive cancers in clinical trial
Histology image of a patient whose metastatic cancer went into complete remission after receiving a new immunotherapy treatment (Ravetch lab) Over the past 20 years, a class of cancer drugs called CD40 agonist antibodies have shown great promise—and induced great disappointment. While effective at activating the immune system to kill cancer cells in animal models, the drugs had limited impact …
Read More »Abortion drug could help reduce risk of breast cancer, group of medics says | Women’s health
A drug used in medical abortions could help prevent women at high risk of breast cancer from developing the disease, according to an international group of doctors and scientists. However, “stigma” around mifepristone is stopping pharmaceutical companies from investigating its potential as a new treatment doctors could offer to reduce the risk of breast cancer, they say. Companies appear reluctant …
Read More »From gene hunter to drug hunter
Howard Chang wasn’t looking for a change from his job at Stanford, where he worked as both a genomic researcher and a dermatologist. His busy lab there was focused on understanding how regulatory programmes drive disease — unveiling for example how long-non-coding RNA (lncRNA) underpins autoimmunity in women and how extrachromosomal DNA (ecDNA) fuels cancer. And with five biotech startups …
Read More »